Stockscreener 앱 받기
2.75
4.56%
0.12
Nrx Pharmaceuticals Inc (NRXP) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
30.20%
-5.512
|
-7.897 | -6.528 | -4.332 | -6.062 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
30.20%
-5.512
|
-7.897 | -6.528 | -4.332 | -6.062 |
Net Income/Loss
|
30.20%
-5.512
|
-7.897 | -6.528 | -4.332 | -6.062 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
자본화:
|
볼륨(24시간):